Comparative Assessment of Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective Inhibition

Read full text
Authors: Alejandro Feito, Natàlia DeMoya-Valenzuela, Cristian Privat, Andrés R. Tejedor, Marco DelValle-Carrillo, Sara Cembellín, Lucía Paniagua-Herranz, Adiran Garaizar, J. Oller-Iscar, Alberto Ocana, Jorge R. Espinosa
Cited by: 3
References: 86

Abstract

Accurate prediction of inhibitor selectivity across protein paralogues remains a central challenge in computational drug discovery. Here, we perform a comparative assessment of three computational methods─Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA), Absolute Binding Free Energy (ABFE) and Umbrella Sampling (US) calculations─in their ability to recapitulate PARP1 versus PARP2 selectivity for eight clinically relevant PARP enzyme inhibitors used in ovarian, breast, and prostate tumors, among others. We demonstrate how MM/PBSA calculations offer rapid and qualitative insights but show pronounced sensitivity to the chosen static conformational pose, being particularly challenging for ligands with subtle energetic differences between distinct protein paralogues. In contrast, both ABFE and US calculations using atomistic models with explicit solvent result in substantially improved agreement with experimental binding affinities. The ABFE method exhibits the strongest quantitative correlation with experimental binding free energy differences, remarkably reproducing selectivity trends even among nearly isoenergetic complexes. Notably, our structural contact analysis reveals how contact connectivity controls ligand selectivity, providing valuable mechanistic and molecular insight into the key residues that stabilize each inhibitor in both protein enzymes. Together, our multimethod computational study contributes to elucidating potential chemical modifications across the ligand chemical space to enhance potency and specificity, informing the future design and evaluation of selective inhibitors for precision oncology, including therapies targeting homologous recombination-deficient cancers.

Fields of Study & Subjects

PARP inhibition in cancer therapy Computational Drug Discovery Methods Protein Structure and Dynamics

Publication details

Journal / source
Journal of Chemical Information and Modeling
Publisher
American Chemical Society (ACS)
Volume
66
Issue
9
Pages
5315–5330
Publication date
18 April 2026
Language
EN